EMAIL THIS PAGE TO A FRIEND

Journal of proteome research

Identification of sialylated glycoproteins in Doxorubicin-treated hepatoma cells with glycoproteomic analyses.


PMID 25158113

Abstract

Sialylation is one of the most important types of glycosylation involved in carcinogenesis and establishment of cancer stemness. We previously showed that increased sialylation is a characteristic glycan change in cancer stem cells (CSCs) from hepatocellular carcinoma. However, the identities of glycoproteins targeted for sialylation remain unknown. In the present study, we identified glycoproteins targeted for sialylation in doxorubicin (DXR)-treated hepatocarcinoma cell line, Huh7, using glycoproteomic analyses. Since CSCs constitute a small subset of cells within carcinoma cell lines, it is difficult to identify sialylated proteins using general glycoproteomic strategies. It is known that treatment with anticancer drug can condense CSCs, we used DXR to concentrate CSCs. In DXR-treated Huh7 cells, isobaric tag for relative and absolute quantitation (iTRAQ) analysis identified 17 sialylated glycoproteins. Most of the identified glycoproteins were cancer-associated proteins. Furthermore, two proteins of approximately 70 kDa were detected using Sambucus sieboldoana agglutinin (SSA) blot analysis and identified as beta-galactosidase and alpha-2-HS-glycoprotein (fetuin-A) by SSA precipitation followed by liquid chromatography-tandem mass spectrometry analyses. Sialylation levels of fetuin-A were increased in DXR-treated Huh7 cell lysates. These changes in sialylation of glycoproteins might be involved in the establishment of cancer stemness.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB1407004
Anti-HYOU1 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB2105677
Anti-HYOU1 antibody produced in rabbit, affinity isolated antibody
HPA049296
Anti-HYOU1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
PRS3627
Anti-LAMP-2 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
L0668
Anti-LAMP2 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2701987
Anti-LAMP2 antibody produced in rabbit
SAB2702058
Anti-LAMP2 antibody produced in rabbit
HPA029100
Anti-LAMP2 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1401635
Anti-LAMP3 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB2101316
Anti-LAMP3 antibody produced in rabbit, affinity isolated antibody
SAB2701141
Anti-LAMP3 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
HPA051467
Anti-LAMP3 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
AV45277
Anti-LSAMP antibody produced in rabbit, affinity isolated antibody
SAB2500735
Anti-P4HA1 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB1406212
Anti-P4HA1 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA007599
Anti-P4HA1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
HPA026593
Anti-P4HA1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
WH0010525M1
Monoclonal Anti-HYOU1 antibody produced in mouse, clone 6F7, purified immunoglobulin, buffered aqueous solution
SAB1402250
Monoclonal Anti-LAMP2 antibody produced in mouse, clone 2G10, purified immunoglobulin, buffered aqueous solution